Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · HealthEquity (HQY)

HealthEquity to terminate CTO Eli Rosner without cause effective April 17, 2026

Neutral Impact 3 of 5 leadership Written later

HealthEquity said it will terminate the employment of Chief Technology Officer Eli Rosner without cause, effective April 17, 2026. Sunil Rajasekar, the company's Executive Vice President, Chief Product and Strategy Officer, will oversee the technology organization from that date.

Key points

  • Eli Rosner, Chief Technology Officer, will leave the company without cause effective April 17, 2026.
  • Sunil Rajasekar, Executive Vice President, Chief Product and Strategy Officer, will take over oversight of the technology organization.
  • Rosner's severance is tied to a release of claims and continued compliance with restrictive covenants, per terms described in the May 13, 2025 proxy statement.
  • Rajasekar has served in his current role since January 2026; earlier he was CEO of Billtrust through August 2025.

The filing

CompanyHealthEquity (HQY)
Form8-K, current report
Filed with the SECApr 6, 2026, 5:01 PM ET
Accession number0001428336-26-000014

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.